Skip to main content

FDA Approvals

Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma

Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer

Jakafi a New Treatment Option for Chronic Graft-versus-Host Disease

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-versus-Host Disease

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

Trodelvy Receives New Indication for Advanced Urothelial Cancer

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

Page 8 of 21
Results 71 - 80 of 202